The PROTXX precision healthcare platform integrates wearable sensor and machine learning innovations to replace bulky and expensive clinical equipment and time-consuming testing procedures for a variety of neurodegenerative medical conditions in which patients suffer from impairments to multiple physiological systems. PROTXX solves the difficult problem of identifying and quantifying these multiple different impairments, enhancing patient care with easy-to-use, low-cost, in-clinic and remote assessments.
Current clinical neurology, rehabilitation medicine, and sports medicine applications of the PROTXX platform include stroke, concussions, elderly frailty, Parkinson’s disease, multiple sclerosis, peripheral neuropathies, and neurosurgeries. These medical conditions together impact 100’s of millions of patients worldwide, and each one on its own generates annual healthcare costs between 30 billion and 70 billion dollars in the U.S. alone.
How Does it Work
A PROTXX Physiological Vibration Acceleration (phybrata) sensor is placed behind the patient or the athlete’s ear. The unique impairment classification and quantification capabilities leverage the critical contributions made by all major physiological systems for precise biomechanical stabilization of the head and eyes as the body’s reference for balance and movement. The Protxx platform analyses the sensors’ readings and enables sensitive detection and remote monitoring of neurological, sensory, and musculoskeletal impairments.
A one-minute phybrata test can quantify normal and pathological physiological performance in patients with conditions such as concussion, stroke, peripheral neuropathy, multiple sclerosis, and Parkinson’s disease. The technology is currently being used by clinical neurology and rehabilitation providers, sports medicine clinics, primary care physicians in family and elderly care, and physical/occupational therapists.
No single wearable sensor anywhere else on the body can match these capabilities.
The PROTXX mobile app allows phybrata tests to be administered by non-expert operators in less than one minute to a single test subject or simultaneously to multiple test subjects. Both in-clinic and remote patient assessments are supported. PROTXX cloud-based data storage, analytics, and reporting services utilize the phybrata signals to enhance the management of complex medical conditions by classifying and quantifying underlying impairments, and monitoring patient responses to treatment, medication, and rehabilitation.